NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Maxar Technologies Inc. (NYSE: MAXR)’s sale to Advent International for $53.00 per share in cash. If you are a Maxar shareholder, click here to learn more about your legal rights and options.

Amryt Pharma Plc (NASDAQ: AMYT)’s sale to Chiesi Farmaceutici S.p.A. Per the terms of the proposed transaction, Chiesi would acquire Amryt for $14.50 in cash per American Depositary Share (ADS) of Amryt plus Contingent Value Rights of up to $2.50 per ADS payable if certain milestones related to Amryt’s product Filsuvez® are achieved. If you are an Amryt shareholder, click here to learn more about your rights and options.

AlerisLife Inc. (NASDAQ: ALR)’s sale to ABP Acquisition LLC for $1.31 per share in cash. If you are an AlerisLife shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.